BSX

What BSX’s 100% Beat Rate and Negative Post-Earnings Drift Actually Mean

Boston Scientific (BSX) has beaten Wall Street estimates in all of its last eight reported quarters, giving it a beat rate of 8/8, or 100%. The average earnings surprise across those quarters is 5%. That means the company has consistently delivered actual EPS above the official consensus, though the margin of beat has varied: the most recent quarter, reported 2026-07-29, delivered actual EPS of $0.86 against an estimate of $0.835, a 3% surprise. Before that, on 2026-04-22, the beat was 1.5% ($0.80 vs. $0.788), and on 2025-10-22 it was 5% ($0.75 vs. $0.714).

Despite that perfect beat streak, the average 5-day price move in the five trading days after earnings across those quarters is -6%, with the drift direction classified as “down.” In the trailing four quarters, the post-earnings five-day returns were null% on 2026-07-29, -11.9% on 2026-04-22, -2.69% on 2026-02-04, and -3.42% on 2025-10-22. Only the second-most-recent report produced a positive one-day move, +1.26%; the most recent close-to-report session fell -0.09%, the February 2026 report rallied +2.83% the next day, and the October 2025 report slipped -1.41% the next day. A beat, in other words, has not reliably translated into sustained upside in the days that followed.

Options-Flow Dynamics Around the October 28 Report

The next scheduled earnings date is October 28, 2026, before the open, with a consensus EPS estimate of $0.80. Heading into that event, options markets typically price elevated implied volatility, because the cost of protection and the premium of directional bets rise as the uncertainty of the earnings release increases. Traders then watch whether implied volatility contracts after the report—a pattern known as post-earnings volatility crush—regardless of which direction the stock moves. Since the historical record shows a one-day reaction that can be positive or flat, but a five-day drift that has averaged -6%, options positioning can be shaped by expectations of not just the binary outcome but the speed and direction of any follow-through move.

With BSX trading at $46.73, below its 50-day EMA of $47.62 and with an RSI of 58.2, the market is neither extremely overbought nor deeply oversold going into the report. That technical setup can influence how options market makers hedge their exposure around the event, affecting where support and resistance levels are watched by active traders.

What a Disciplined Trader Watches For

Given the pattern of 100% beats but an average -6% five-day post-earnings drift, a disciplined trader separates the headline result from the market’s reaction. First, compare the actual EPS to the official $0.80 consensus and to the magnitude of prior beats. The trailing four surprises of 5%, 2.4%, 1.5%, and 3% set a historical context for what “enough” looks like. Second, monitor the next-day price move versus the five-day drift: BSX’s last four next-day moves were -0.09%, +1.26%, +2.83%, and -1.41%, while the corresponding five-day moves were null%, -11.9%, -2.69%, and -3.42%. That divergence means the first session may not define the full post-event trajectory.

Finally, traders watch whether price holds or breaks the 50-day EMA area around $47.62 and whether RSI confirms momentum or divergence after the report. These technical reference points help frame follow-through risk without forcing a directional forecast. BSX operates in the Healthcare/Medical Devices sector, so any shift in guidance or commentary on procedure volumes can also affect how the market prices forward growth, independent of the headline EPS beat or miss.

For a deeper dive into how institutional analysts, hedge funds, and proprietary models are positioned on BSX heading into the October 28 report, look at the full institutional verdict on the ticker page.